Market revenue in 2022 | USD 17.4 million |
Market revenue in 2030 | USD 43.4 million |
Growth rate | 12.1% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.3% in 2022. Horizon Databook has segmented the Germany veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Leading market participants are implementing strategies, such as product launches and acquisitions, to strengthen their competencies, product portfolios, & capabilities. The strong presence of significant companies, such as Boehringer Ingelheim International GmbH, is positively influencing market growth.
For instance, in April 2022, Boehringer Ingelheim introduced RenuTend, a new stem cell therapy to expedite the healing of tendon and suspensory ligament injuries in horses. In addition, animal stem cell therapy is gaining popularity due to its capacity to utilize animals' stem cells to extend treatment for diseases or disorders.
Animals who receive this therapy live longer. Numerous health problems, including arthritis, degenerative joint disorders, and ligament and tendon injuries in animals, have seen a large increase in instances in recent years. This factor is promoting the growth of the market for veterinary regenerative medicines.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Germany veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account